Press release
Global Biologics Contract Manufacturing Market to grow at a CAGR of 9.39% by 2032, Evaluates DelveInsight | AGC Biologics, Boehringer Ingelheim, Catalent, Cell Therapies, Charles River Laboratories, FUJIFILM Diosynth Biotechnologies, KBI Biopharma, Kemwel
Additionally, the surge in product development activities by both emerging biotech companies and major pharmaceutical firms is fostering greater collaboration with CMOs and CDMOs to speed up market entry and reduce costs. Collectively, these trends are fueling the growth of the biologics contract manufacturing market, addressing the industry's need for high-quality, scalable, and flexible manufacturing solutions throughout the forecast period from 2025 to 2032.
DelveInsight's "Biologics Contract Manufacturing Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Biologics Contract Manufacturing companies actively working in the market.
To know more about why North America is leading the market growth in the Biologics Contract Manufacturing market, get a snapshot of the report Biologics Contract Manufacturing Market Trends
https://www.delveinsight.com/sample-request/biologics-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Biologics Contract Manufacturing Overview
Biologics contract manufacturing refers to outsourcing the production of biologic drugs-such as monoclonal antibodies, vaccines, cell and gene therapies, and recombinant proteins-to specialized third-party companies known as Contract Manufacturing Organizations (CMOs) or Contract Development and Manufacturing Organizations (CDMOs). These manufacturers provide services including process development, scale-up, formulation, analytical testing, and large-scale production under strict regulatory standards (e.g., GMP). Biologics contract manufacturing helps pharmaceutical and biotech companies reduce infrastructure costs, speed up time to market, and access specialized expertise and technologies needed for the complex manufacturing of biologic therapies.
DelveInsight Analysis: The global biologics contract manufacturing market size was valued at USD 23,240.99 million in 2024 and is anticipated to grow at a CAGR of 9.39% from 2025 to 2032, reaching approximately USD 47,494.63 million by 2032.
Biologics Contract Manufacturing Market Insights
Geographically, North America is anticipated to lead the biologic contract manufacturing organization market in 2024, driven by multiple factors. The region's dominance is fueled by the growing burden of chronic diseases like cancer, autoimmune disorders, and cardiovascular conditions, which is increasing the demand for biologics. North America also hosts numerous major biopharmaceutical companies and contract manufacturing organizations (CMOs) equipped with advanced manufacturing technologies, including expertise in cell culture, fermentation, and downstream processing. Additionally, rising R&D investments, supportive regulatory policies, and government efforts to promote biotech innovation are further boosting market expansion. The presence of key industry players, a strong biologics development pipeline, and increasing outsourcing by pharmaceutical companies further solidify North America's leading position in this sector.
To read more about the latest highlights related to Biologics Contract Manufacturing, get a snapshot of the key highlights entailed in the Biologics Contract Manufacturing
https://www.delveinsight.com/report-store/biologics-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Biologics Contract Manufacturing Market Report
• In October 2024, Enzene Biosciences unveiled EnzeneXTM 2.0, the latest advancement of its Fully-Connected Continuous ManufacturingTM (FCCMTM) technology for biologics, at CPHI Milan 2024.
• In August 2024, NEC Bio Therapeutics and AGC Biologics announced a partnership to produce personalized cancer vaccines.
• Thus, owing to such developments in the market, rapid growth will be observed in the Biologics Contract Manufacturing market during the forecast period
Key Players in the Biologics Contract Manufacturing Market
Some of the key market players operating in the Biologics Contract Manufacturing market include- AGC Biologics, Boehringer Ingelheim, Catalent, Cell Therapies, Charles River Laboratories, FUJIFILM Diosynth Biotechnologies, KBI Biopharma, Kemwell Biopharma, Lonza, Miltenyi Biotec, Minaris Regenerative Medicine, Samsung Biologics, Sandoz, Vetter Pharma, WuXi Biologics, Sanofi, Kymab, Novartis Pharma AG, Lindy Biosciences, Siegfried AG, and others.
Which MedTech key players in the Biologics Contract Manufacturing market are set to emerge as the trendsetter explore @ Key Biologics Contract Manufacturing Companies
https://www.delveinsight.com/sample-request/biologics-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Biologics Contract Manufacturing Market Landscape
As more companies prioritize personalized medicine approaches, including antibody-drug conjugates (ADCs) and immune checkpoint inhibitors, the demand for biologics contract manufacturing is steadily increasing. Monoclonal antibodies, in particular, are significantly influencing the expansion of the biologics manufacturing market. For example, in December 2024, Eurofins CDMO Alphora Inc. announced plans to build a 112,000 sq ft GMP biologics manufacturing facility in Mississauga, Ontario. This facility will focus on producing monoclonal antibodies and protein therapies for both clinical trials and commercial use, with completion targeted for 2026.
Collectively, these factors are expected to strengthen this market segment, driving the overall growth of the global biologics contract manufacturing industry.
Scope of the Biologics Contract Manufacturing Market Report
• Coverage: Global
• Study Period: 2022-2032
• Biologics Contract Manufacturing Market Segmentation By Manufactured Type: Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, and Others
• Biologics Contract Manufacturing Market Segmentation By Type of Expression System : Microbial, Mammalian, and Others
• Biologics Contract Manufacturing Market Segmentation By Application Type: Oncology, Immunology, Cardiology, Neurological, and Others
• Biologics Contract Manufacturing Market Segmentation By End-User: Hospitals and Specialty Clinics
• Biologics Contract Manufacturing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Biologics Contract Manufacturing Companies: AGC Biologics, Boehringer Ingelheim, Catalent, Cell Therapies, Charles River Laboratories, FUJIFILM Diosynth Biotechnologies, KBI Biopharma, Kemwell Biopharma, Lonza, Miltenyi Biotec, Minaris Regenerative Medicine, Samsung Biologics, Sandoz, Vetter Pharma, WuXi Biologics, Sanofi, Kymab, Novartis Pharma AG, Lindy Biosciences, Siegfried AG, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Biologics Contract Manufacturing market will grow by 2032? Click to get a snapshot of the Biologics Contract Manufacturing Market Analysis
https://www.delveinsight.com/sample-request/biologics-contract-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Biologics Contract Manufacturing Market Report Introduction
2 Biologics Contract Manufacturing Market Executive summary
3 Regulatory and Patent Analysis
4 Biologics Contract Manufacturing Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Biologics Contract Manufacturing Market
7 Biologics Contract Manufacturing Market Layout
8 Global Company Share Analysis - Key Biologics Contract Manufacturing Companies
9 Company and Product Profiles
10 Project Approach
11 Biologics Contract Manufacturing Market Drivers
12 Biologics Contract Manufacturing Market Barriers
13 About DelveInsight
Latest Reports by DelveInsight
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Dry Eye Disease Market: https://www.delveinsight.com/report-store/dry-eye-disease-market-insights
• Nonalcoholic Steatohepatitis Market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
• Female Infertility Market: https://www.delveinsight.com/report-store/female-infertility-market
• Gonorrhea Market: https://www.delveinsight.com/report-store/gonorrhea-market
• Bone Densitometers Market: https://www.delveinsight.com/report-store/bone-densitometers-market
• Structural Heart Devices Market: https://www.delveinsight.com/report-store/structural-heart-devices-market-market
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biologics Contract Manufacturing Market to grow at a CAGR of 9.39% by 2032, Evaluates DelveInsight | AGC Biologics, Boehringer Ingelheim, Catalent, Cell Therapies, Charles River Laboratories, FUJIFILM Diosynth Biotechnologies, KBI Biopharma, Kemwel here
News-ID: 4096579 • Views: …
More Releases from DelveInsight Business Research
Primary Biliary Cholangitis Market Expected to Experience Major Growth by 2034, …
DelveInsight's "Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology as well as the Primary Biliary Cholangitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Primary Biliary Cholangitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Biliary Cholangitis…
Advanced Renal Cell Carcinoma Pipeline 2025: Therapies, MOA Insights, and Key Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Advanced Renal Cell Carcinoma Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis b …
DelveInsight's "Alport Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Alport Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alport Syndrome Market Forecast
https://www.delveinsight.com/sample-request/alport-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Angioedema Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Angioedema pipeline constitutes 20+ key companies continuously working towards developing 20+ Angioedema treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Angioedema Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
